Author Archives: Natalie Themm
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Springboard Enterprises Announces 2026 Women’s Health Accelerator Cohort
Women-led companies join Springboard’s accelerator to advance innovation across the women’s health landscape.
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’
Utah’s Life Sciences Community Takes Off at the 2026 Entrepreneur & Investor Summit
The 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit) served as a launchpad for innovation
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Launch Represents Significant Step to Broader Commercialization
RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox
RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution
Cytiva Sponsors Operational Excellence Case Study Competition
Cytiva Sponsors Operational Excellence Case Study Competition
